APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,492,609 | +9.0% | 65,526 | +161.0% | 0.31% | -0.3% |
| Q2 2023 | $2,287,521 | +106.1% | 25,110 | +49.3% | 0.32% | +110.0% |
| Q1 2023 | $1,109,711 | -56.7% | 16,824 | -55.1% | 0.15% | -61.3% |
| Q3 2022 | $2,562,000 | -7.0% | 37,504 | -38.4% | 0.39% | +59.7% |
| Q2 2022 | $2,754,000 | +12.4% | 60,894 | -23.9% | 0.24% | +60.9% |
| Q4 2019 | $2,450,000 | +113.6% | 80,017 | +68.1% | 0.15% | +122.1% |
| Q3 2019 | $1,147,000 | +22.5% | 47,602 | +28.9% | 0.07% | +23.6% |
| Q2 2019 | $936,000 | +69.0% | 36,920 | +30.0% | 0.06% | +77.4% |
| Q1 2019 | $554,000 | – | 28,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |